IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling
Stefanie M. Bader(The University of Melbourne), Marcel Doerflinger(The University of Melbourne), Cody C. Allison(The University of Melbourne), Andreas Strasser(The University of Melbourne), Smitha R. Georgy(The University of Melbourne), Marc Pellegrini(The University of Melbourne), James P. Cooney(The University of Melbourne), Liana Mackiewicz(Walter and Eliza Hall Institute of Medical Research), Marco J. Herold(The University of Melbourne), Kathryn C. Davidson(Australian Regenerative Medicine Institute), Merle Dayton(Walter and Eliza Hall Institute of Medical Research), L.R. Scherer(University of Tennessee Health Science Center), Jan Schaefer(The University of Melbourne)
Cited by 8
Related Papers
Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.
|The EMBO Journal|1995|788
The BCL-2 protein family, BH3-mimetics and cancer therapy
|Cell Death and Differentiation|2015|540
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
|The EMBO Journal|2020|499
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
|Genes & Development|2012|417
Glucocorticoids in T cell apoptosis and function
|Cellular and Molecular Life Sciences|2005|390